Edition:
International

Biotechnology & Medical Research

Page 1

Relief's Partner Acer Therapeutics Plans NDA Submission For Acer-001 In Q3 2021

Tuesday, 25 May 2021 01:00am EDT

May 25 (Reuters) - RELIEF THERAPEUTICS HOLDING SA ::RELIEF'S PARTNER ACER THERAPEUTICS PLANS NDA SUBMISSION FOR ACER-001 IN Q3 2021 FOLLOWING PRE-NDA MEETING WITH FDA.ACER-001 IS BEING DEVELOPED IN COLLABORATION WITH RELIEF.

Idorsia Says European Commission Approves Ponvory (Ponesimod) For Treatment Of Adults With Relapsing Forms Of Multiple Sclerosis

Tuesday, 25 May 2021 01:00am EDT

May 25 (Reuters) - IDORSIA LTD ::EUROPEAN COMMISSION APPROVES PONVORY (PONESIMOD) FOR THE TREATMENT OF ADULTS WITH RELAPSING FORMS OF MULTIPLE SCLEROSIS WITH ACTIVE DISEASE DEFINED BY CLINICAL OR IMAGING FEATURES.IDORSIA IS ENTITLED TO RECEIVE QUARTERLY PAYMENTS OF 8% OF NET SALES OF PONESIMOD PRODUCTS FROM ACTELION.

Promore Pharma Q4 Operating Loss Narrows To SEK 6.9 Mln

Tuesday, 23 Feb 2021 08:32am EST

Feb 23 (Reuters) - Promore Pharma AB ::YEAR-END REPORT 2020.Q4 NET SALES AMOUNTED TO MSEK 0 (1.5).Q4 OPERATING LOSS FOR PERIOD WAS MSEK -6.9 (-9.4).MANAGEMENT AND BOARD ARE CURRENTLY PERFORMING A COMPREHENSIVE EVALUATION OF STRATEGIC ALTERNATIVES WITHIN MAIN PROJECTS.AIM IS TO ANNOUNCE THIS REVISED STRATEGY DURING MARCH/APRIL 2021.

Nabriva Therapeutics And Sinovant Sciences Restructure License Agreement For Xenleta For Community-Acquired Bacterial Pneumonia In China

Monday, 7 Dec 2020 07:00am EST

Dec 7 (Reuters) - Nabriva Therapeutics PLC ::NABRIVA THERAPEUTICS AND SINOVANT SCIENCES RESTRUCTURE LICENSE AGREEMENT FOR XENLETA FOR COMMUNITY-ACQUIRED BACTERIAL PNEUMONIA IN CHINA.NABRIVA THERAPEUTICS PLC - ACCELERATES MILESTONE PAYMENTS TO NABRIVA, INCLUDING Q4 2020 PAYMENT OF $1 MILLION.NABRIVA THERAPEUTICS - RESTRUCTURED AGREEMENT PROVIDES ADDITIONAL MANUFACTURING COLLABORATION TO EXPEDITE XENLETA DELIVERY TO GREATER CHINA PATIENTS.NABRIVA THERAPEUTICS PLC - RESTRUCTURED AGREEMENT ACCELERATES COMPONENTS OF $5 MILLION MILESTONE PAYMENT TO NABRIVA.

Paion Says Juergen Beck Will Leave Management Board On Dec. 31

Tuesday, 1 Dec 2020 08:00am EST

Dec 1 (Reuters) - PAION AG ::DR. JUERGEN BECK WILL LEAVE THE PAION AG MANAGEMENT BOARD ON 31 DECEMBER 2020 AS PLANNED.DR. JIM PHILLIPS, CEO OF PAION AG, WILL TAKE OVER RESPONSIBILITIES FROM DR. BECK.

Senestech Restructures Board For Commercial Growth

Wednesday, 11 Nov 2020 04:04pm EST

Nov 11 (Reuters) - Senestech Inc ::SENESTECH RESTRUCTURES BOARD FOR COMMERCIAL GROWTH.SENESTECH INC - ELECTED THREE NEW DIRECTORS TO ITS BOARD OF DIRECTORS.SENESTECH INC - JULIE WILLIAMS WILL BE STEPPING DOWN AS A DIRECTOR.

Secarna Pharmaceuticals And Evotec Form Strategic Partnership In Antisense Therapy

Wednesday, 5 Aug 2020 01:30am EDT

Aug 5 (Reuters) - :DGAP-NEWS: SECARNA PHARMACEUTICALS AND EVOTEC FORM STRATEGIC PARTNERSHIP IN THE FIELD OF ANTISENSE THERAPY.

Northern Data Says SBI Becomes New Strategic Shareholder

Thursday, 2 Jul 2020 02:39pm EDT

July 3 (Reuters) - Northern Data AG ::SAID ON THURSDAY SBI BECOMES NEW STRATEGIC SHAREHOLDER.THE STRATEGIC SHAREHOLDERS HAVE AGREED TO A LOCK-UP OF UP TO 36 MONTHS SUBJECT TO CUSTOMARY EXCEPTIONS..

Avita Medical Says Court Approved Scheme Meeting Where Avita Therapeutics To Become Parent Co

Monday, 11 May 2020 01:37am EDT

May 11 (Reuters) - Avita Medical Ltd ::AVITA MEDICAL-COURT APPROVED SCHEME MEETING UNDER WHICH AVITA THERAPEUTICS, NEW CO IN US TO BECOME PARENT CO (ADDS DROPPED WORD 'MEETING').AVITA MEDICAL-COURT APPROVED ORDERS TO CONVENE MEETING OF CO'S SHAREHOLDERS TO CONSIDER & IF THOUGHT FIT APPROVE PROPOSED SCHEME OF ARRANGEMENT.AVITA MEDICAL- BOARD UNANIMOUSLY RECOMMENDS CO'S SHAREHOLDERS VOTE IN FAVOUR OF RESOLUTION TO APPROVE SCHEME.

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary